PNC Financial Services Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34K | Buy |
9,160
+1,257
| +16% | +$4.66K | ﹤0.01% | 3326 |
|
|
2025
Q1 | $25.5K | Sell |
7,903
-1,221
| -13% | -$3.94K | ﹤0.01% | 3430 |
|
|
2024
Q4 | $50.8K | Buy |
9,124
+3,630
| +66% | +$20.2K | ﹤0.01% | 3097 |
|
|
2024
Q3 | $59.4K | Buy |
5,494
+1,134
| +26% | +$12.3K | ﹤0.01% | 2989 |
|
|
2024
Q2 | $91.5K | Buy |
4,360
+4,332
| +15,471% | +$90.9K | ﹤0.01% | 2687 |
|
|
2024
Q1 | $892 | Sell |
28
-4
| -13% | -$127 | ﹤0.01% | 4386 |
|
|
2023
Q4 | $648 | Buy |
+32
| New | +$648 | ﹤0.01% | 4372 |
|